Hereditary Cancer Gene Panel

Hereditary cancers are caused by inherited mutations in specific genes that can be passed from one generation to another. The Hereditary Cancer Gene Panel is a comprehensive blood test that evaluates multiple genes at once to assess inherited cancer risk. It can help detect various types of genetic changes such as single nucleotide variants (SNVs), small insertions or deletions (INDELs), and copy number variations (CNVs). These changes can indicate a higher risk of developing cancer.

This panel is particularly useful for individuals with a strong family history of cancer, especially if multiple family members, including younger individuals, are affected. Understanding these genetic risks allows doctors to recommend proactive steps, including early cancer screening, lifestyle modifications, and personalized monitoring.

The Hereditary Cancer Gene Panel helps in evaluating the risk for a wide range of cancers, including breast, ovarian, pancreatic, prostate, colorectal, thyroid, renal, skin, endocrine, gynecological, nervous system cancers, as well as paragangliomas and Li-Fraumeni syndrome. By identifying these risks early, patients and healthcare providers can take preventive measures and make informed treatment and lifestyle decisions.

For this test, it is important to submit the clinical history, histopathology report, previous test results, and a doctor’s prescription at the time of sample collection. The Tata 1mg consolidated Test Requisition Form (TRF) must also be duly filled and submitted.

Lab test results may vary across different laboratories. Abnormal test results require an expert interpretation. Therefore, never try to self-medicate at home based solely on these results, and always consult a doctor for proper understanding of the test results.

Note: Genetic counseling can be provided. If interested, please send the request to this email id: [email protected]